NCT05248984View on ClinicalTrials.gov

Dosing of Ketorolac Impacts Post-cesarean paiN manaGemenet (KING)

CompletedOBSERVATIONAL
Enrollment

92

Participants

Timeline

Start Date

June 8, 2022

Primary Completion Date

November 30, 2023

Study Completion Date

November 30, 2023

Conditions
Post Cesarean Pain
Interventions
DRUG

Ketorolac

"Once the decision has been made by the primary obstetrics (OB) provider to proceed with cesarean delivery, participants will be randomized in to one of two groups:~* Single dose of intravenous (IV) Ketorolac 30mg Vs.~* Single dose of intravenous (IV) Ketorolac 60mg"

Trial Locations (1)

43210

The Ohio State University Wexner Medical Center OB/GYN Maternal and Fetal Medicine, Columbus

All Listed Sponsors
lead

Ohio State University

OTHER